The potential management of resistant infections with non-antibiotics.
J Antimicrob Chemother. 1997.
PMID: 9338482
Review.
Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1997 | 1 |
| 2015 | 1 |
| 2022 | 2 |
| 2024 | 0 |
Search Results
4 results
Results by year
Citations
1
article
found by citation matching
Search results
Filters applied: . Clear all
Page 1
The potential management of resistant infections with non-antibiotics.
Kristiansen JE, Amaral L.
Kristiansen JE, et al.
J Antimicrob Chemother. 1997 Sep;40(3):319-27. doi: 10.1093/jac/40.3.319.
J Antimicrob Chemother. 1997.
PMID: 9338482
Review.
The antimicrobial properties of compounds such as phenothiazines, as well as those of other neurotropic compounds, have only been investigated sporadically, and their application to management of microbial infections has not been evaluated. A review of the literatur …
The antimicrobial properties of compounds such as phenothiazines, as well as those of other neurotropic compounds, have only been investigat …
Item in Clipboard
Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management.
Sardana K, Gupta T, Garg VK, Ghunawat S.
Sardana K, et al.
Expert Rev Anti Infect Ther. 2015 Jul;13(7):883-96. doi: 10.1586/14787210.2015.1040765. Epub 2015 May 29.
Expert Rev Anti Infect Ther. 2015.
PMID: 26025191
Review.
Antibiotic resistance in cutaneous Propionobacterium is a global problem. As a general rule, resistance levels are high to macrolides, trimethoprim/sulfamethoxazole and clindamycin, while tetracyclines and levofloxacin have low resistance potential. .. …
Antibiotic resistance in cutaneous Propionobacterium is a global problem. As a general rule, resistance levels are high to mac …
Item in Clipboard
Drug repurposing strategy: An emerging approach to identify potential therapeutics for treatment of bovine mastitis.
Muzammil I, Ijaz M, Saleem MH, Ali MM.
Muzammil I, et al.
Microb Pathog. 2022 Oct;171:105691. doi: 10.1016/j.micpath.2022.105691. Epub 2022 Aug 19.
Microb Pathog. 2022.
PMID: 35995254
The current study was designed to characterize methicillin-resistant Staphylococcus aureus (MRSA) isolated from bovine milk, along with its response to antibiotics, and ultimately reverse its mechanism of resistance by modulation with non-antibiotics. …
The current study was designed to characterize methicillin-resistant Staphylococcus aureus (MRSA) isolated from bovine milk, along wi …
Item in Clipboard
In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae.
Chung WY, Abdul Rahim N, Mahamad Maifiah MH, Hawala Shivashekaregowda NK, Zhu Y, Wong EH.
Chung WY, et al.
Front Pharmacol. 2022 Aug 4;13:880352. doi: 10.3389/fphar.2022.880352. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35991875
Free PMC article.
Multidrug-resistant (MDR) Klebsiella pneumoniae is a top-prioritized Gram-negative pathogen with a high incidence in hospital-acquired infections. ...Taken together, a systematic framework has been developed to facilitate the clinical translation of antibiotic-re …
Multidrug-resistant (MDR) Klebsiella pneumoniae is a top-prioritized Gram-negative pathogen with a high incidence in hospital-acquire …
Item in Clipboard
Cite
Cite